Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|14|1601-1609

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.14, 2015-10, pp. : 1601-1609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of an MR-compatible blood sampler for PET

By Breuer J   Grazioso R   Zhang N   Schmand M   Wienhard K  

Physics in Medicine and Biology, Vol. 55, Iss. 19, 2010-10 ,pp. : 5883-5893

IOP Publishing

Access to resources Recommend Favorite

Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5‐13C]glutamine

By  

MAGNETIC RESONANCE IN MEDICINE, Vol. 73, Iss. 6, 2015-06 ,pp. : 2296-2305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 1053-1807, Iss. 4, 2015-10 ,pp. : 1048-1056

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 4, 2015-10 ,pp. : 1048-1056

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Roles of PET and PET/CT in the Diagnosis and Management of Prostate Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 226-233

Karger

Access to resources Recommend Favorite